Periostat
|
WikiDoc Resources for Periostat |
|
Articles |
|---|
|
Most recent articles on Periostat |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Periostat at Clinical Trials.gov Clinical Trials on Periostat at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Periostat
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Periostat Discussion groups on Periostat Directions to Hospitals Treating Periostat Risk calculators and risk factors for Periostat
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Periostat |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Periostat is a medication against advanced gum disease (chronic periodontitis), produced by CollaGenex Pharmaceuticals. The active compound is the antibiotic doxycycline, 20mg of which is contained in each tablet of Periostat. The medication is a prescription only drug, and is recommended to be taken orally in combination with a deep cleaning procedure known as scaling and root planing.